GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.4884
+0.0314 (6.87%)
Feb 18, 2026, 4:00 PM EST - Market closed
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $13.02 million as of February 19, 2026. Its market cap has increased by 160.34% in one year.
Market Cap
13.02M
Enterprise Value
10.49M
1-Year Change
160.34%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $13.02M, a decrease of -84.35%. That is a compound annual growth rate of -20.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 5.20M | -37.35% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 13.30M |
| Cadrenal Therapeutics | 12.94M |
| OSR Holdings | 12.73M |
| BioLineRx | 12.67M |
| NewcelX | 12.63M |
| Kairos Pharma | 12.45M |
| BioCardia | 12.10M |
| CytoMed Therapeutics | 11.77M |